Laura J Esserman

72PUBLICATIONS
288CO-AUTHORS
Cancer geneticsPredictive and prognostic markersData qualityMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|May 23, 2026
WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.

|Apr 22, 2026
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

|Dec 09, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf

|Nov 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design.

Allison Fiscalini, Kelly Blum, Kirkpatrick Fergus

|Oct 30, 2025
Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial.

Ali B Abbasi, Kathleen D Liu, Derek W Russell

|Oct 25, 2025
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial.

Oscar Danielsson, Huma Dar, Gizeh Perez-Tenorio

Pageof 12

Frequent Collaborators

27 joint publications

Laura Van't Veer

22 joint publications

Gillian L Hirst

16 joint publications

Nola M Hylton

15 joint publications

Lamorna Brown-Swigart